Search Results - "Parekh, D.R."

Long-Term Outcomes of Adults with Congenital Heart Disease Supported by Durable Continuous-Flow Ventricular Assist Devices by Frankel, W.C., Broda, C.R., Nair, A.P., Dreyer, W.J., Tunuguntla, H.P., Parekh, D.R., Frazier, O.H., Hickey, E.J., Adachi, I., Civitello, A.B.

“…End-stage heart failure is a leading cause of morbidity and mortality in adult congenital heart disease (ACHD) patients; however, advanced therapies such as…”
Get full text

Use of Percutaneous Continuous Flow Ventricular Assist Devices in Adults with Congenital Heart Disease by Broda, C.R., Frankel, W.C., Nair, A.P., Tunuguntla, H.P., Anders, M.C., Tume, S.C., Hickey, E.J., Qureshi, A.M., Parekh, D.R., Civitello, A.B., Adachi, I.

“…Adult congenital heart disease (ACHD) patients are disproportionally affected by heart failure and cardiogenic shock compared to the general population…”
Get full text

The Role of Impella in the Management of Cardiogenic Shock in Heart Transplant Patients at a Pediatric Center by Tunuguntla, H.P., Choudhry, S., Puri, K., Spinner, J.A., Denfield, S.W., Dreyer, W.J., Price, J.F., Hope, K., Qureshi, A.M., Parekh, D.R., Adachi, I., Tume, S.C.

“…Graft failure after heart transplant (HTx) due to allograft rejection or coronary artery vasculopathy (CAV) can result in cardiogenic shock requiring…”
Get full text